Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications
Top Cited Papers
- 1 July 2019
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 20 (7), e368-e377
- https://doi.org/10.1016/s1470-2045(19)30318-3
Abstract
No abstract availableThis publication has 87 references indexed in Scilit:
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety AspectsAnnals of Surgical Oncology, 2013
- Renal and Hepatic Toxicities After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)Annals of Surgical Oncology, 2013
- Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyJournal of Clinical Oncology, 2012
- Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of conceptSurgical Endoscopy, 2011
- Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French StudyJournal of Clinical Oncology, 2010
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional ExperienceJournal of Clinical Oncology, 2009
- Surgical Innovation and Evaluation 3 No surgical innovation without evaluation: the IDEAL recommendationsThe Lancet, 2009
- Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal OriginJournal of Clinical Oncology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal Of Cancer, 2009
- Neoadjuvant treatment of gastric cancer with peritoneal disseminationEuropean Journal of Surgical Oncology, 2006